Crossmark

Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition

Crossref DOI link: https://doi.org/10.1186/s40425-019-0808-5

Published Online: 2019-11-21

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Xuanye

Zhou, Yixin

Chen, Chen

Fang, Wenfeng

Cai, Xiuyu

Zhang, Xiaoshi

Zhao, Ming

Zhang, Bei

Jiang, Wenqi

Lin, Zuan

Ma, Yuxiang

Yang, Yunpeng

Huang, Yan

Zhao, Hongyun

Xu, Ruihua

Hong, Shaodong http://orcid.org/0000-0002-5632-6857
Zhang, Li
Funding

Funding for this research was provided by:

National Key R&D Program of China (2016YFC0905500 and 2016YFC0905503)

National Natural Science Funds of China (81972898, 81602005, 81702283, 81872499, and 81602011)

Excellent Young Talents Fund Program of Higher Education Institutions of Anhui Province (16zxyc04)

Central Basic Scientific Research Fund for Colleges-Young Teacher Training Program of Sun Yat-sen University (17ykpy81)

Science and Technology Program of Guangdong Province (2017B020227001)
License Information

Text and Data Mining valid from 2019-11-21
More Information

Article History

Received: 23 August 2019

Accepted: 6 November 2019

First Online: 21 November 2019

Ethics approval and consent to participate

: This study was approved by the Sun Yat-sen University Cancer Center Institutional Review Board.

: Not applicable.

: The authors declare that they have no competing interests.